APA (7th ed.) Citation

Muntner, P., Davis, B. R., Cushman, W. C., Bangalore, S., Calhoun, D. A., Pressel, S. L., . . . Group*, A. C. R. (2014). Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: Results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension (0194911X), 64(5), 1012. https://doi.org/10.1161/HYPERTENSIONAHA.114.03850

Chicago Style (17th ed.) Citation

Muntner, Paul, et al. "Treatment-resistant Hypertension and the Incidence of Cardiovascular Disease and End-stage Renal Disease: Results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)." Hypertension (0194911X) 64, no. 5 (2014): 1012. https://doi.org/10.1161/HYPERTENSIONAHA.114.03850.

MLA (9th ed.) Citation

Muntner, Paul, et al. "Treatment-resistant Hypertension and the Incidence of Cardiovascular Disease and End-stage Renal Disease: Results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)." Hypertension (0194911X), vol. 64, no. 5, 2014, p. 1012, https://doi.org/10.1161/HYPERTENSIONAHA.114.03850.